Dr. Tayar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
SUNY Downstate Health Sciences UniversityFellowship, Rheumatology, 2002 - 2004
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 1998 - 2002
St Joseph's University Medical SchoolClass of 1997
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
TX State Medical License 2008 - 2026
WA State Medical License 2023 - 2026
GA State Medical License 2023 - 2025
LA State Medical License 2004 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 184 citationsNephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experienceOmar Mamlouk, Umut Selamet, Shana Machado, Maen Abdelrahim, William F Glass
Journal for Immunotherapy of Cancer. 2019-01-06 - 45 citationsDistinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.Sang T Kim, Yanshuo Chu, Mercy Misoi, Maria E Suarez-Almazor, Jean H Tayar
Nature Communications. 2022-04-12 - 26 citationsSelective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events.Faisal Fa'ak, Maryam Buni, Adewunmi Falohun, Huifang Lu, Juhee Song
Journal for Immunotherapy of Cancer. 2023-06-01
Authored Content
- Myositis as an Adverse Event of Immune Checkpoint Blockade for Cancer TherapyMay 2018
- Myositis as an Adverse Event of Immune Checkpoint Blockade for Cancer TherapyMay 2018
- Myositis as an Adverse Event of Immune Checkpoint Blockade for Cancer TherapyMay 2018
Press Mentions
Metastatic Melanoma Survivor Finds Hope in Clinical TrialsAugust 20th, 2019- After My Acute Myeloid Leukemia Treatment, Check-Ups Feel like a ReunionJuly 30th, 2019
LupusMarch 18th, 2016
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
